Free Trial

Immunocore (IMCR) News Today

Immunocore logo
$30.63 +0.17 (+0.56%)
Closing price 04:00 PM Eastern
Extended Trading
$30.64 +0.02 (+0.05%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Immunocore Holdings plc stock logo
Marshall Wace LLP Reduces Holdings in Immunocore Holdings plc (NASDAQ:IMCR)
Marshall Wace LLP reduced its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 85.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 28,610 shares of the company's stock after selling 170,833 shares during the period. Marshall Wace LLP owned 0.
Immunocore Holdings plc stock logo
Price T Rowe Associates Inc. MD Acquires 29,832 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Price T Rowe Associates Inc. MD boosted its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,187,530 shares of t
Immunocore Holdings plc stock logo
Wells Fargo & Company MN Sells 11,120 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Wells Fargo & Company MN decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 13.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 71,935 shares of the company's stock after selling
Immunocore Holdings: A Name On My Watch List
Immunocore Holdings plc stock logo
Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company's stock after sell
Immunocore Holdings plc stock logo
T. Rowe Price Investment Management Inc. Buys 200,373 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
T. Rowe Price Investment Management Inc. boosted its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 3.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,700,2
Immunocore Holdings plc stock logo
Legal & General Group Plc Acquires 20,163 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Legal & General Group Plc lifted its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 136,875 shares of the company's stock after b
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Stock Price Down 2.4% - What's Next?
Immunocore (NASDAQ:IMCR) Shares Down 2.4% - Time to Sell?
Immunocore Holdings plc stock logo
Jump Financial LLC Has $962,000 Stake in Immunocore Holdings plc (NASDAQ:IMCR)
Jump Financial LLC lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 46.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,600 shares of the comp
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Stock Price Up 5% - Here's Why
Immunocore (NASDAQ:IMCR) Stock Price Up 5% - Time to Buy?
Immunocore Holdings plc stock logo
Immunocore Holdings plc (NASDAQ:IMCR) Given Average Rating of "Moderate Buy" by Analysts
Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and e
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Given New $50.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. dropped their target price on Immunocore from $54.00 to $50.00 and set an "overweight" rating for the company in a report on Monday.
Immunocore Holdings plc stock logo
Fmr LLC Sells 18,341 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Fmr LLC lessened its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,817,699 shares of the company's stock
J.P. Morgan Remains a Buy on Immunocore Holdings (IMCR)
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Receives "Buy" Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $71.00 price objective on shares of Immunocore in a report on Thursday.
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Reaches New 12-Month Low - Should You Sell?
Immunocore (NASDAQ:IMCR) Hits New 52-Week Low - What's Next?
Immunocore Holdings (IMCR) Gets a Buy from Needham
Immunocore Holdings plc stock logo
Mizuho Has Lowered Expectations for Immunocore (NASDAQ:IMCR) Stock Price
Mizuho dropped their price target on shares of Immunocore from $38.00 to $33.00 and set a "neutral" rating on the stock in a research note on Monday.
Immunocore Holdings plc stock logo
Massachusetts Financial Services Co. MA Has $13.54 Million Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)
Massachusetts Financial Services Co. MA decreased its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 7.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 459,045 shares of the company's stock after selling 39,176 shares
Immunocore price target lowered to $33 from $38 at Mizuho
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Sets New 52-Week Low - Here's What Happened
Immunocore (NASDAQ:IMCR) Reaches New 52-Week Low - Here's What Happened
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Sees Unusually-High Trading Volume - Should You Buy?
Immunocore (NASDAQ:IMCR) Sees Strong Trading Volume - Time to Buy?
Immunocore Holdings plc stock logo
Wellington Management Group LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)
Wellington Management Group LLP lessened its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 6.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,617,055 shares of the company's stock after selling 431,778 shares during
Immunocore Holdings plc stock logo
Groupama Asset Managment Takes $17.70 Million Position in Immunocore Holdings plc (NASDAQ:IMCR)
Groupama Asset Managment acquired a new position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 600,000 shares of the company's stock, valued at ap
Immunocore Holdings plc stock logo
Immunocore Holdings plc (NASDAQ:IMCR) Shares Acquired by BIT Capital GmbH
BIT Capital GmbH grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 182.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,840 shares of the compan
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Shares Gap Up - Time to Buy?
Immunocore (NASDAQ:IMCR) Shares Gap Up - Here's What Happened
Immunocore Holdings plc stock logo
Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Rating of "Moderate Buy" from Analysts
Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the thirteen analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and eight
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Shares Gap Up Following Insider Buying Activity
Immunocore (NASDAQ:IMCR) Shares Gap Up on Insider Buying Activity
Immunocore Holdings plc stock logo
Insider Buying: Immunocore Holdings plc (NASDAQ:IMCR) Director Acquires 807,338 Shares of Stock
Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) Director Bros. Advisors Lp Baker purchased 807,338 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were acquired at an average cost of $29.72 per share, for a total transaction of $23,994,085.36. Following the purchase, the director now owns 2,144,060 shares of the company's stock, valued at $63,721,463.20. This represents a 60.40 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Immunocore Holdings plc stock logo
Immunocore Holdings plc (NASDAQ:IMCR) Shares Purchased by Primecap Management Co. CA
Primecap Management Co. CA increased its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,668,550 shares of the company's s
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $71.00 price objective on shares of Immunocore in a research report on Wednesday.
Immunocore Holdings plc stock logo
HC Wainwright Reaffirms "Buy" Rating for Immunocore (NASDAQ:IMCR)
HC Wainwright reiterated a "buy" rating and set a $100.00 price target on shares of Immunocore in a research report on Wednesday.
Immunocore reports promising HIV trial results
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Hits New 12-Month Low - Time to Sell?
Immunocore (NASDAQ:IMCR) Reaches New 52-Week Low - What's Next?
Barclays Remains a Buy on Immunocore Holdings (IMCR)
Immunocore Holdings plc stock logo
Immunocore (NASDAQ:IMCR) Receives Equal Weight Rating from Morgan Stanley
Morgan Stanley restated an "equal weight" rating and set a $35.00 target price on shares of Immunocore in a report on Friday.
Immunocore assumed with an Equal Weight at Morgan Stanley
Immunocore Holdings (IMCR) Receives a Buy from Goldman Sachs
Immunocore Holdings (IMCR) Gets a Hold from Mizuho Securities
Immunocore Holdings plc stock logo
Immunocore FY2027 EPS Forecast Increased by HC Wainwright
Immunocore Holdings plc (NASDAQ:IMCR - Free Report) - Stock analysts at HC Wainwright upped their FY2027 earnings estimates for shares of Immunocore in a research note issued to investors on Friday, February 28th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings p
Get Immunocore News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter.

IMCR Media Mentions By Week

IMCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMCR
News Sentiment

1.22

0.72

Average
Medical
News Sentiment

IMCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMCR Articles
This Week

3

5

IMCR Articles
Average Week

Get Immunocore News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IMCR) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners